1-8 of 8
Paul White
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety of Autologous Stem Cell Transplantation in Patients with Known HTLV-1 Infection: A Case Series of 4 Patients

Vishal K Gupta, MD, Paul White, MD, Vaishali Sanchorawala, MD, Karen Quillen, MD MPH, Shayna Sarosiek, MD, Dina Brauneis, NP, John Mark Sloan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5738.
https://doi.org/10.1182/blood-2018-99-110230
Published: 2018
Journal Articles

Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling

Paul S. Hole, Joanna Zabkiewicz, Chinmay Munje, Zarabeth Newton, Lorna Pearn, Paul White, Nuria Marquez, Robert K. Hills, Alan K. Burnett, Alex Tonks, Richard L. Darley
Journal: Blood
Blood (2013) 122 (19): 3322–3330.
https://doi.org/10.1182/blood-2013-04-491944
Published: 2013
Includes: Supplemental data
Journal Articles

The Efficacy of the FLT3 Inhibitor Lestaurtinib in AML Depends on Adequate Plasma Inhibitory Activity (PIA), and Is Unaffected by Rising FLT Ligand Levels: An Update of the NCRI AML15 & 17 Trials

Steven Knapper, DM MRCP FRCPath, Paul White, PhD, Mark J. Levis, MD, PhD, Robert K Hills, MA, MSc, DPhil, Nigel H. Russell, MD, Alan Burnett, MD, ChB, FRCP, FRCPath, FMedSci
Journal: Blood
Blood (2011) 118 (21): 421.
https://doi.org/10.1182/blood.V118.21.421.421
Published: 2011
Journal Articles

FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo

Clinical Trials & Observations
Takashi Sato, Xiaochuan Yang, Steven Knapper, Paul White, B. Douglas Smith, Steven Galkin, Donald Small, Alan Burnett, Mark Levis
Journal: Blood
Blood (2011) 117 (12): 3286–3293.
https://doi.org/10.1182/blood-2010-01-266742
Published: 2011
Journal Articles

Analysis of the Interaction of Induction Regimens with P-Glycoprotein Expression In Patients with Acute Myeloid Leukaemia: Results From the MRC AML15 Trial

Monica Pallis, PhD, Paul White, PhD, Robert Hills, MA, MSc, DPhil, Martin Grundy, BSc, Nigel H. Russell, MD, Alan Burnett
Journal: Blood
Blood (2010) 116 (21): 2724.
https://doi.org/10.1182/blood.V116.21.2724.2724
Published: 2010
Journal Articles

Detection of Immunophenotypic Residual Disease After Induction Therapy Is An Independent Prognostic Factor for Duration of Remission In Older AML Patients Treated Intensively

Sylvie Freeman, Robert Hills, MA, MSc, DPhil, Paul Virgo, Steve Couzens, Mark W Lowdell, BSc, MSc, PhD, FRCPath, Christopher J McNamara, Paul White, Alan Burnett
Journal: Blood
Blood (2010) 116 (21): 2714.
https://doi.org/10.1182/blood.V116.21.2714.2714
Published: 2010
Journal Articles

Increased Plasma FLT3 Ligand Levels Following Chemotherapy May Interfere with the Clinical Efficacy of FLT3 Inhibitors.

Takashi Sato, Steven Knapper, Alan K Burnett, Paul White, Mark Levis
Journal: Blood
Blood (2009) 114 (22): 937.
https://doi.org/10.1182/blood.V114.22.937.937
Published: 2009
Journal Articles

Competing Influences of Genetic and Leukaemia-Specific Factors on P-Glycoprotein Expression in Blasts from 817 Patients Entered into the NCRN AML14 and 15 Trials.

Claire H. Seedhouse, PhD, Martin Grundy, BSc, Paul White, PhD, Yun Li, MSc, Janet Fisher, BSc, Darya Yakunina, MD, Anthony Moorman, PhD, Nigel Russell, MD, Alan Burnett, MD, Monica Pallis, PhD
Journal: Blood
Blood (2006) 108 (11): 835.
https://doi.org/10.1182/blood.V108.11.835.835
Published: 2006